| Author (Corporate) | European Medicines Agency |
|---|---|
| Series Title | Press Release |
| Series Details | EMA/CHMP/676755/2012 (19.10.12) |
| Publication Date | 19/10/2012 |
| Content Type | News |
|
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP), in October 2012, reviewed preliminary research results by the Finnish National Institute of Health and Welfare (THL) investigating differences in the immunological response triggered by different pandemic influenza vaccines as a potential root cause for the development of narcolepsy in persons vaccinated with Pandemrix. Narcolepsy is a rare sleep disorder that causes a person to fall asleep suddenly and unexpectedly. |
|
| Source Link | http://www.emea.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2012/10/news_detail_001636.jsp&mid=WC0b01ac058004d5c1 |
| Related Links |
|
| Subject Categories | Health |
| Countries / Regions | Europe |
